Indaptus Therapeutics, Inc. Common Stock (INDP) is a publicly traded Healthcare sector company. As of September 30, 2026, INDP trades at $2.30 with a market cap of $438.37M and a P/E ratio of -1.56. INDP moved -15.44% today. Year to date, INDP is -2.06%; over the trailing twelve months it is -4.68%. Its 52-week range spans $0.92 to $47.60. Rallies surfaces INDP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Indaptus Therapeutics extends deadline for $24 million private placement closing to Oct. 16: Indaptus Therapeutics extended the closing deadline for its private placement of common stock, expected to raise about $24 million, to Oct. 16, 2026, from Sept. 29. Purchasers’ funding deadline and related termination rights were also extended to Oct. 16.
| Metric | Value |
|---|---|
| Price | $2.30 |
| Market Cap | $438.37M |
| P/E Ratio | -1.56 |
| EPS | $-1.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $47.60 |
| 52-Week Low | $0.92 |
| Volume | 408.89K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-15.42M |
| Gross Margin | 0.00% |
INDP analyst coverage data. Average price target: $0.00.